Safety and Efficacy of Combined Ruxolitinib and Decitabine in Patients with Blast-Phase MPN and Post-MPN AML: Results of a Phase I Study (Myeloproliferative Disorders Research Consortium 109 trial)

Rampal Raajit K.; Mascarenhas John O.; Kosiorek Heidi E.; Berenzon Dmitriy; Hexner Elizabeth; Abboud Camille N.; Kremyanskaya Marina; Weinberg Rona Singer; Salama Mohamed E.; Tognoni Gianni; Prosperini Giuseppe; Di Lelio Alessandra; Serone Eliseo; Marfisi Lorenzo; Sandy Lonette; Heaney Mark Lawrence; Levine Ross L.; Mesa Ruben A.; Dueck Amylou C.; Hoffman Ronald

首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Safety and Efficacy of Combined Ruxolitinib and Decitabine in Patients with Blast-Phase MPN and Post-MPN AML: Results of a Phase I Study (Myeloproliferative Disorders Research Consortium 109 trial)

【24h】

Safety and Efficacy of Combined Ruxolitinib and Decitabine in Patients with Blast-Phase MPN and Post-MPN AML: Results of a Phase I Study (Myeloproliferative Disorders Research Consortium 109 trial)

机译：劳伦替尼和酵母蛋白酶患者的安全性和有效性，患者患者和蛋白质的疗效：I阶段研究结果（Myeloproiferative Surencounters Consortium 109试验）

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Blood: The Journal of the American Society of Hematology》 |2016年第22期|共6页
作者
Rampal Raajit K.; Mascarenhas John O.; Kosiorek Heidi E.; Berenzon Dmitriy; Hexner Elizabeth; Abboud Camille N.; Kremyanskaya Marina; Weinberg Rona Singer; Salama Mohamed E.; Tognoni Gianni; Prosperini Giuseppe; Di Lelio Alessandra; Serone Eliseo; Marfisi Lorenzo; Sandy Lonette; Heaney Mark Lawrence; Levine Ross L.; Mesa Ruben A.; Dueck Amylou C.; Hoffman Ronald;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类血液及淋巴系疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Safety and Efficacy of Combined Ruxolitinib and Decitabine in Patients with Blast-Phase MPN and Post-MPN AML: Results of a Phase I Study (Myeloproliferative Disorders Research Consortium 109 trial) [J] . Rampal Raajit K., Mascarenhas John O., Kosiorek Heidi E., Blood: The Journal of the American Society of Hematology . 2016,第22期

机译：劳伦替尼和酵母蛋白酶患者的安全性和有效性，患者患者和蛋白质的疗效：I阶段研究结果（Myeloproiferative Surencounters Consortium 109试验）
2. Proposed criteria for response assessment in patients treated in clinical trials for myeloproliferative neoplasms in blast phase (MPN-BP): Formal recommendations from the post-myeloproliferative neoplasm acute myeloid leukemia consortium [J] . MascarenhasJ., HeaneyM.L., NajfeldV., Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis . 2012,第12期

机译：初生阶段骨髓增生性肿瘤临床试验中治疗患者的反应评估建议标准（MPN-BP）：骨髓增生后肿瘤急性髓样白血病联合会的正式建议
3. Ruxopeg, a Multi-Center Bayesian Phase 1/2 Adaptive Randomized Trial of the Combination of Ruxolitinib and Pegylated Interferon Alpha 2a in Patients with Myeloproliferative Neoplasm (MPN)-Associated Myelofibrosis [J] . Kiladjian Jean-Jacques, Soret-Dulphy Juliette, Resche-Rigon Matthieu, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：Ruxopeg，一种多中心贝叶斯期1/2适应性随机试验，ruxolitinib和Pegylated干扰素α2a患者中的肌酚瘤肿瘤（MPN） - 分配肌纤维化症的组合
4. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
5. Proposed Criteria for Response Assessment in Patients Treated in Clinical Trials for Myeloproliferative Neoplasms in Blast Phase (MPN-BP); Formal Recommendations from the Post-Myeloproliferative Neoplasm Acute Myeloid Leukemia Consortium (Post-MPN AML Consortium) [O] . John Mascarenhas, Mark L Heaney, Vesna Najfeld, -1

机译：提出的患者临床试验中患者的响应评估标准（MPN-BP）治疗的临床试验中的临床试验中的临床试验;从髓内瘤性肿瘤急性髓白血病联盟的正式建议（MPN AML联盟）
6. Phase 2 study of ruxolitinib and decitabine in patients with myeloproliferative neoplasm in accelerated and blast phase [O] . John O. Mascarenhas, Raajit K. Rampal, Heidi E. Kosiorek, 2020

机译：加速和冲压阶段髓原肿瘤患者罗索立尼和酵母的第2阶段研究

Safety and Efficacy of Combined Ruxolitinib and Decitabine in Patients with Blast-Phase MPN and Post-MPN AML: Results of a Phase I Study (Myeloproliferative Disorders Research Consortium 109 trial)

著录项

引文网络

相似文献

相关主题

期刊订阅